MANNKIND CORP Business Operations Contracts & Agreements

24 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sixth Amendment to Commercial Supply Agreement between MannKind Corporation and United Therapeutics Corporation
Supply Agreements
MANNKIND CORP
Biotechnology
2025
Fifth Amendment to Commercial Supply Agreement between MannKind Corporation and United Therapeutics Corporation
Supply Agreements
MANNKIND CORP
Biotechnology
2025
Third Amendment to Supply Agreement between MannKind Corporation and Amphastar Pharmaceuticals, Inc.
Supply Agreements
MANNKIND CORP
Biotechnology
2024
Second Amendment to Supply Agreement between MannKind Corporation and Amphastar Pharmaceuticals, Inc.
Supply Agreements
MANNKIND CORP
Biotechnology
2024
License and Collaboration Agreement between MannKind Corporation and United Therapeutics Corporation
License Agreements
MANNKIND CORP
Biotechnology
NY
2024
Fourth Amendment to Commercial Supply Agreement between MannKind Corporation and United Therapeutics Corporation
Supply Agreements
MANNKIND CORP
Biotechnology
2023
Third Amendment to Commercial Supply Agreement between MannKind Corporation and United Therapeutics Corporation
Supply Agreements
MANNKIND CORP
Biotechnology
2023
Second Amendment to Commercial Supply Agreement between MannKind Corporation and United Therapeutics Corporation
Modification Agreements
MANNKIND CORP
Biotechnology
2023
First Amendment to Commercial Supply Agreement between MannKind Corporation and United Therapeutics Corporation
Modification Agreements
MANNKIND CORP
Biotechnology
2021
Commercial Supply Agreement between MannKind Corporation and United Therapeutics Corporation (Tyvaso DPI)
Supply Agreements
MANNKIND CORP
Biotechnology
NY
2021
Supply Agreement between MannKind Corporation and Amphastar France Pharmaceuticals S.A.S. (July 31, 2014)
Supply Agreements
MANNKIND CORP
Biotechnology
DE
2021
Fourth Amendment to Supply Agreement, dated December 24, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc
Supply Agreements
MANNKIND CORP
Biotechnology
2019
Third Amendment to Supply Agreement between MannKind Corporation and Amphastar Pharmaceuticals, Inc.
Supply Agreements
MANNKIND CORP
Biotechnology
2018
Controlled Equity Offering Sales Agreement between MannKind Corporation and Cantor Fitzgerald & Co. (February 27, 2018)
Equity Distribution Agreements
MANNKIND CORP
Biotechnology
NY
2018
Second Amendment to Supply Agreement between MannKind Corporation and Amphastar Pharmaceuticals, Inc.
Supply Agreements
MANNKIND CORP
Biotechnology
2017
First Amendment to Supply Agreement between MannKind Corporation and Amphastar Pharmaceuticals, Inc.
Supply Agreements
MANNKIND CORP
Biotechnology
2017
Supply Agreement between MannKind Corporation and Amphastar France Pharmaceuticals S.A.S. (July 31, 2014)
Supply Agreements
MANNKIND CORP
Biotechnology
NY
2014
Supply Agreement between MannKind Corporation and Sanofi-Aventis Deutschland GmbH (August 11, 2014)
Supply Agreements
MANNKIND CORP
Biotechnology
NY
2014
$350,000,000 Promissory Note between MannKind Corporation and The Mann Group LLC dated February 26, 2009
Note Agreements
MANNKIND CORP
Biotechnology
NY
2009
Supply Agreement between MannKind Corporation and N.V. Organon for Recombinant Human Insulin
Supply Agreements
MANNKIND CORP
Biotechnology
CT
2008
Supply Agreement between Vaupell, Inc. and MannKind Corporation dated December 31, 2004
Supply Agreements
MANNKIND CORP
Biotechnology
DE
2005
License and Collaboration Agreement between MannKind Corporation and United Therapeutics Corporation (September 3, 2018)
License Agreements
MANNKIND CORP
Biotechnology
NY
2018
Settlement Agreement between MannKind Corporation, Technosphere International C.V., MannKind Netherlands B.V., and sanofi-aventis U.S. LLC (November 9, 2016)
Settlement Agreements
MANNKIND CORP
Biotechnology
NY
2017
License and Collaboration Agreement between MannKind Corporation, Technosphere International C.V., MannKind Netherlands B.V., and Sanofi-Aventis Deutschland GmbH (August 11, 2014)
License Agreements
MANNKIND CORP
Biotechnology
NY
2014